Clozapine resistance-Augmentation strategies

European Neuropsychopharmacology

Volumn 23, Issue 4, 2013, Pages 338-

  Tiihonen, Jari ^a,b,c   Leucht, Stefan ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; AMISULPRIDE; ARIPIPRAZOLE; CITALOPRAM; CLOZAPINE; ICOSAPENTAENOIC ACID; LAMOTRIGINE; MIRTAZAPINE; PLACEBO; RISPERIDONE; SULPIRIDE;

DRUG RESISTANCE; LETTER; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PSYCHOPHARMACOLOGY;

EID: 84881544912     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.04.020     Document Type: Letter

References (3)

1. Porcelli, S., Balzarro, B., Serretti, A., 2012. Clozapine resistance: augmentation strategies. Eur. Neuropsychopharmacol. 22, 165-182.
2. Sommer, I.E., Begemann, M.J., Temmerman, A., Leucht, S., 2011. Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review. Schizophr. Bull. http://dxdoi.org/10.1093/schbul/sbr004 (2011 Mar 21. [Epub ahead of print]).
3. Tiihonen, J., Wahlbeck, K., Kiviniemi, V., 2009. The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis. Schizophr. Res. 109, 10-14.